These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 30923088

  • 1. Moving Toward a Consensus DSC-MRI Protocol: Validation of a Low-Flip Angle Single-Dose Option as a Reference Standard for Brain Tumors.
    Schmainda KM, Prah MA, Hu LS, Quarles CC, Semmineh N, Rand SD, Connelly JM, Anderies B, Zhou Y, Liu Y, Logan B, Stokes A, Baird G, Boxerman JL.
    AJNR Am J Neuroradiol; 2019 Apr; 40(4):626-633. PubMed ID: 30923088
    [Abstract] [Full Text] [Related]

  • 2. Optimization of Acquisition and Analysis Methods for Clinical Dynamic Susceptibility Contrast MRI Using a Population-Based Digital Reference Object.
    Semmineh NB, Bell LC, Stokes AM, Hu LS, Boxerman JL, Quarles CC.
    AJNR Am J Neuroradiol; 2018 Nov; 39(11):1981-1988. PubMed ID: 30309842
    [Abstract] [Full Text] [Related]

  • 3. Multisite Concordance of DSC-MRI Analysis for Brain Tumors: Results of a National Cancer Institute Quantitative Imaging Network Collaborative Project.
    Schmainda KM, Prah MA, Rand SD, Liu Y, Logan B, Muzi M, Rane SD, Da X, Yen YF, Kalpathy-Cramer J, Chenevert TL, Hoff B, Ross B, Cao Y, Aryal MP, Erickson B, Korfiatis P, Dondlinger T, Bell L, Hu L, Kinahan PE, Quarles CC.
    AJNR Am J Neuroradiol; 2018 Jun; 39(6):1008-1016. PubMed ID: 29794239
    [Abstract] [Full Text] [Related]

  • 4. Utility of Percentage Signal Recovery and Baseline Signal in DSC-MRI Optimized for Relative CBV Measurement for Differentiating Glioblastoma, Lymphoma, Metastasis, and Meningioma.
    Lee MD, Baird GL, Bell LC, Quarles CC, Boxerman JL.
    AJNR Am J Neuroradiol; 2019 Sep; 40(9):1445-1450. PubMed ID: 31371360
    [Abstract] [Full Text] [Related]

  • 5. Effects of MRI Protocol Parameters, Preload Injection Dose, Fractionation Strategies, and Leakage Correction Algorithms on the Fidelity of Dynamic-Susceptibility Contrast MRI Estimates of Relative Cerebral Blood Volume in Gliomas.
    Leu K, Boxerman JL, Ellingson BM.
    AJNR Am J Neuroradiol; 2017 Mar; 38(3):478-484. PubMed ID: 28034995
    [Abstract] [Full Text] [Related]

  • 6. Identification of a Single-Dose, Low-Flip-Angle-Based CBV Threshold for Fractional Tumor Burden Mapping in Recurrent Glioblastoma.
    Anil A, Stokes AM, Karis JP, Bell LC, Eschbacher J, Jennings K, Prah MA, Hu LS, Boxerman JL, Schmainda KM, Quarles CC.
    AJNR Am J Neuroradiol; 2024 Oct 03; 45(10):1545-1551. PubMed ID: 38782593
    [Abstract] [Full Text] [Related]

  • 7. Systematic assessment of multi-echo dynamic susceptibility contrast MRI using a digital reference object.
    Stokes AM, Semmineh NB, Nespodzany A, Bell LC, Quarles CC.
    Magn Reson Med; 2020 Jan 03; 83(1):109-123. PubMed ID: 31400035
    [Abstract] [Full Text] [Related]

  • 8. Improved Leakage Correction for Single-Echo Dynamic Susceptibility Contrast Perfusion MRI Estimates of Relative Cerebral Blood Volume in High-Grade Gliomas by Accounting for Bidirectional Contrast Agent Exchange.
    Leu K, Boxerman JL, Cloughesy TF, Lai A, Nghiemphu PL, Liau LM, Pope WB, Ellingson BM.
    AJNR Am J Neuroradiol; 2016 Aug 03; 37(8):1440-6. PubMed ID: 27079371
    [Abstract] [Full Text] [Related]

  • 9. Consistency of normalized cerebral blood volume values in glioblastoma using different leakage correction algorithms on dynamic susceptibility contrast magnetic resonance imaging data without and with preload.
    Hedderich D, Kluge A, Pyka T, Zimmer C, Kirschke JS, Wiestler B, Preibisch C.
    J Neuroradiol; 2019 Feb 03; 46(1):44-51. PubMed ID: 29753641
    [Abstract] [Full Text] [Related]

  • 10. Impact of Software Modeling on the Accuracy of Perfusion MRI in Glioma.
    Hu LS, Kelm Z, Korfiatis P, Dueck AC, Elrod C, Ellingson BM, Kaufmann TJ, Eschbacher JM, Karis JP, Smith K, Nakaji P, Brinkman D, Pafundi D, Baxter LC, Erickson BJ.
    AJNR Am J Neuroradiol; 2015 Dec 03; 36(12):2242-9. PubMed ID: 26359151
    [Abstract] [Full Text] [Related]

  • 11. A cross-sectional study to test equivalence of low- versus intermediate-flip angle dynamic susceptibility contrast MRI measures of relative cerebral blood volume in patients with high-grade gliomas at 1.5 Tesla field strength.
    Shiroishi MS, Weinert D, Cen SY, Varghese B, Dondlinger T, Prah M, Mendoza J, Nazemi S, Ameli N, Amini N, Shohas S, Chen S, Bigjahan B, Zada G, Chen T, Neman-Ebrahim J, Chang EL, Chow FE, Fan Z, Yang W, Attenello FJ, Ye J, Kim PE, Patel VN, Lerner A, Acharya J, Hu LS, Quarles CC, Boxerman JL, Wu O, Schmainda KM.
    Front Oncol; 2023 Dec 03; 13():1156843. PubMed ID: 37799462
    [Abstract] [Full Text] [Related]

  • 12. Discrimination between Glioblastoma and Solitary Brain Metastasis: Comparison of Inflow-Based Vascular-Space-Occupancy and Dynamic Susceptibility Contrast MR Imaging.
    Li X, Wang D, Liao S, Guo L, Xiao X, Liu X, Xu Y, Hua J, Pillai JJ, Wu Y.
    AJNR Am J Neuroradiol; 2020 Apr 03; 41(4):583-590. PubMed ID: 32139428
    [Abstract] [Full Text] [Related]

  • 13. Performance of Standardized Relative CBV for Quantifying Regional Histologic Tumor Burden in Recurrent High-Grade Glioma: Comparison against Normalized Relative CBV Using Image-Localized Stereotactic Biopsies.
    Hoxworth JM, Eschbacher JM, Gonzales AC, Singleton KW, Leon GD, Smith KA, Stokes AM, Zhou Y, Mazza GL, Porter AB, Mrugala MM, Zimmerman RS, Bendok BR, Patra DP, Krishna C, Boxerman JL, Baxter LC, Swanson KR, Quarles CC, Schmainda KM, Hu LS.
    AJNR Am J Neuroradiol; 2020 Mar 03; 41(3):408-415. PubMed ID: 32165359
    [Abstract] [Full Text] [Related]

  • 14. "Synthetic" DSC perfusion MRI with adjustable acquisition parameters in brain tumors using dynamic spin-and-gradient-echo echoplanar imaging.
    Sanvito F, Yao J, Cho NS, Raymond C, Telesca D, Pope WB, Everson RG, Salamon N, Boxerman JL, Cloughesy TF, Ellingson BM.
    AJNR Am J Neuroradiol; 2024 Sep 12. PubMed ID: 39242197
    [Abstract] [Full Text] [Related]

  • 15. Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors.
    Paulson ES, Schmainda KM.
    Radiology; 2008 Nov 12; 249(2):601-13. PubMed ID: 18780827
    [Abstract] [Full Text] [Related]

  • 16. Validation of a T1 and T2* leakage correction method based on multiecho dynamic susceptibility contrast MRI using MION as a reference standard.
    Stokes AM, Semmineh N, Quarles CC.
    Magn Reson Med; 2016 Aug 12; 76(2):613-25. PubMed ID: 26362714
    [Abstract] [Full Text] [Related]

  • 17. Bayesian estimation of cerebral perfusion using reduced-contrast-dose dynamic susceptibility contrast perfusion at 3T.
    Nael K, Mossadeghi B, Boutelier T, Kubal W, Krupinski EA, Dagher J, Villablanca JP.
    AJNR Am J Neuroradiol; 2015 Apr 12; 36(4):710-8. PubMed ID: 25430859
    [Abstract] [Full Text] [Related]

  • 18. Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)-MRI estimates of cerebral blood volume (CBV) in human gliomas.
    Ellingson BM, Zaw T, Cloughesy TF, Naeini KM, Lalezari S, Mong S, Lai A, Nghiemphu PL, Pope WB.
    J Magn Reson Imaging; 2012 Jun 12; 35(6):1472-7. PubMed ID: 22281731
    [Abstract] [Full Text] [Related]

  • 19. A comparison of pseudo-continuous arterial spin labelling and dynamic susceptibility contrast MRI with and without contrast agent leakage correction in paediatric brain tumours.
    Novak J, Withey SB, Lateef S, MacPherson L, Pinkey B, Peet AC.
    Br J Radiol; 2019 Feb 12; 92(1094):20170872. PubMed ID: 30358415
    [Abstract] [Full Text] [Related]

  • 20. Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas.
    Boxerman JL, Quarles CC, Hu LS, Erickson BJ, Gerstner ER, Smits M, Kaufmann TJ, Barboriak DP, Huang RH, Wick W, Weller M, Galanis E, Kalpathy-Cramer J, Shankar L, Jacobs P, Chung C, van den Bent MJ, Chang S, Al Yung WK, Cloughesy TF, Wen PY, Gilbert MR, Rosen BR, Ellingson BM, Schmainda KM, Jumpstarting Brain Tumor Drug Development Coalition Imaging Standardization Steering Committee.
    Neuro Oncol; 2020 Sep 29; 22(9):1262-1275. PubMed ID: 32516388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.